NCT06137820View on ClinicalTrials.gov

CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

August 19, 2023

Study Completion Date

December 31, 2023

Conditions
Ankle Injury or Chronic Trauma to the Ankle
Interventions
DEVICE

Cetilar® (topical cream)

Topical cream twice daily for 30 days. An average amount of 5 g per day.

DEVICE

Cetilar Placebo

Cetilar placebo cream matching to Cetilar®. Topical cream twice daily for 30 days. An average amount of 5 g per day

Trial Locations (3)

0160

"LLC Altra Vita", Tbilisi

Unknown

"JSC Evex Hospitals (Caraps Medline)", Tbilisi

"Azienda Sanitaria Locale Viterbo , ASL Viterbo, Dipartimento di Ortopedia (Centro Coordinatore)"

All Listed Sponsors
collaborator

NEA Clinical S.r.l.

UNKNOWN

lead

Pharmanutra S.p.a.

INDUSTRY